RPRD1B and neoplasm: Overexpression of RPRD1B (IHC score ≥ 4) was detected in 78/191 (40.8%) informative GC primary tumor tissues (P < 0.0001) and 44/93 (47.3%) metastatic lymph nodes (P < 0.0001) (Fig. 1D).